Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer.
Li C, Wang J, Hu J, Feng Y, Hasegawa K, Peng X, Duan X, Zhao A, Mikitsh JL, Muzykantov VR, Chacko AM, Pryma DA, Dunn SM, Coukos G.
Li C, et al. Among authors: dunn sm.
Oncotarget. 2014 Aug 30;5(16):6994-7012. doi: 10.18632/oncotarget.2188.
Oncotarget. 2014.
PMID: 25051365
Free PMC article.